Skip to main content
main-content

01.01.2014 | Original paper | Ausgabe 1/2014

Cancer Causes & Control 1/2014

Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data

Zeitschrift:
Cancer Causes & Control > Ausgabe 1/2014
Autoren:
Mandi Yu, Zaria Tatalovich, James T. Gibson, Kathleen A. Cronin
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s10552-013-0310-1) contains supplementary material, which is available to authorized users.

Abstract

Purpose

The lack of individual socioeconomic status (SES) information in cancer registry data necessitates the use of area-based measures to investigate health disparities. Concerns about confidentiality, however, prohibit publishing patients’ residential locations at the subcounty level. We developed a census tract-based composite SES index to be released in place of individual census tracts to minimize the risk of disclosure.

Methods

Two SES indices based on the measures identified in the literature were constructed using factor analysis. The analyses were repeated using the data from the 2000 decennial census and 2005–2009 American Community Survey to create the indices at two time points, which were linked to 2000–2009 Surveillance, Epidemiology, and End Results registry data to estimate incidence and survival rates.

Results

The two indices performed similarly in stratifying census tracts and detecting socioeconomic gradients in cancer incidence and survival. The gradient in the incidence is positive for breast and prostate, and negative for lung cancers, in all races, although the level varies. The positive gradient in survival is more salient for regional-staged breast, colorectal, and lung cancers.

Conclusions

The census tract-based SES index provides a valuable tool for monitoring the disparities in cancer burdens while avoiding potential identity disclosure. This index, divided into tertiles and quintiles, is now available to the researchers on request.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Zusatzmaterial
Supplementary material 1 (DOCX 19 kb)
10552_2013_310_MOESM1_ESM.docx
Supplementary material 2 (PS 11 kb)
10552_2013_310_MOESM2_ESM.ps
Supplementary material 3 (PS 20 kb)
10552_2013_310_MOESM3_ESM.ps
Supplementary material 4 (PS 20 kb)
10552_2013_310_MOESM4_ESM.ps
Supplementary material 5 (DOCX 16 kb)
10552_2013_310_MOESM5_ESM.docx
Supplementary material 6 (PS 21 kb)
10552_2013_310_MOESM6_ESM.ps
Supplementary material 7 (PS 50 kb)
10552_2013_310_MOESM7_ESM.ps
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2014

Cancer Causes & Control 1/2014 Zur Ausgabe
  1. Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise